English | 简体中文 | 繁體中文 | 한국어
 All Press Releases
 Medicine BioTech
Sirnaomics Announces Publication of STP705 Clinical Study Results for Treatment of isSCC in the Peer-Reviewed Journal of Drugs in Dermatology
Jun 16, 2022 11:42 HKT
노보텍 소속 아시아 태평양 및 미국 지역 임원진, ‘바이오 2022’ 참가
Jun 15, 2022 21:00 HKT
富途企业服务专访沛嘉医疗首席运营官潘孔荣
Jun 15, 2022 18:32 HKT
富途企業服務專訪沛嘉醫療首席運營官潘孔榮
Jun 15, 2022 18:28 HKT
中国抗体在美国完成SM17 I期临床试验首例健康受试者给药
Jun 15, 2022 13:05 HKT
中國抗體在美國完成SM17 I期臨床試驗首例健康受試者給藥
Jun 15, 2022 13:04 HKT
SinoMab Dosed First Healthy Subject in Phase I Clinical Trial of SM17 in the U.S.
Jun 15, 2022 13:03 HKT
Breakthrough Cooperation of Legend Capital's Cross-border Portfolio Companies: Innovent and Etana Jointly Announce the Approval of Bevagen by the BPOM
Jun 15, 2022 12:08 HKT
SINGAPORE ANNUAL MEETING: DIA and CoRE Gathering Key Healthcare Experts in Neutral Forum to Discuss Regulatory News and Drug Development
Jun 15, 2022 08:30 HKT
Novotech 的亚太地区和美国领导团队参加 BIO 2022
Jun 15, 2022 06:00 HKT
Novotech 的亞太地區和美國領導團隊參加 BIO 2022
Jun 15, 2022 06:00 HKT
Novotech's APAC and USA Leadership Teams at BIO 2022
Jun 14, 2022 22:00 HKT
Olympus to Use 100% Renewable Electricity at R&D and Manufacturing Sites in Japan
Jun 14, 2022 12:00 HKT
Malaysian Genomics Resource Centre Berhad Gets Affected Issuer Status Uplifted
Jun 13, 2022 12:00 HKT
沛嘉医疗旗下加奇生物Fluxcap®球囊导引导管获批上市
Jun 09, 2022 12:58 HKT
沛嘉醫療旗下加奇生物Fluxcap®球囊導引導管獲批上市
Jun 09, 2022 12:57 HKT
中国抗体公布SN1011新药研究申请获中国国家药品监督管理局药品审评中心受理
Jun 09, 2022 12:50 HKT
中國抗體公佈SN1011新藥研究申請獲中國國家藥品監督管理局藥品審評中心受理
Jun 09, 2022 12:49 HKT
SinoMab Announces IND Application for SN1011 Accepted by NMPA CDE
Jun 09, 2022 12:48 HKT
Verisk 携手安盛再保险在中国推出健康风险评级工具
Jun 08, 2022 09:00 HKT
<< Previous  Next >>
Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: